Ruella, M
Kenderian, S S
Shestova, O
Klichinsky, M
Melenhorst, J J
Wasik, M A
Lacey, S F
June, C H
Gill, S
Article History
First Online: 28 September 2016
Competing interests
: The authors work under a research collaboration involving the University of Pennsylvania and the Novartis Institutes of Biomedical Research, Inc. MR, SSK, MAW, CHK, JJM, and SG are inventors of intellectual property licensed by the University of Pennsylvania to Novartis. This work was supported by grants from the University of Pennsylvania-Novartis Alliance (PI: CHJ and SG), the NIH (5R01CA120409 grant, PI: CHJ), the Lymphoma Research Foundation (2013-2015 MCL E/D, PI: MAW and SG), the SITC (EMD-Serono Cancer Immunotherapy Clinical Fellowship, PI: MR), the AACR (Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research, PI: MR), the SIES-AIL (PI: MR), the NCI (K12 CA090628, PI: SSK) and the NIH (T32-GM008076 to MK).